The pyridazinone compound GFB-8438 (Figure 2) was a highly selective, potent TRPC5 antagonist, which specifically interacted with the TRPC5-Rac1 pathway in podocytes to attenuate FSGS and diabetic nephropathy [20]. This evidence concerns the gene TRPC5 and diabetic kidney disease.